|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.7 TWD | -0.64% |
|
+1.84% | -13.62% |
Medigen Biotechnology Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 1,055.95 million compared to TWD 3,922.01 million a year ago.
Net loss was TWD 675.87 million compared to TWD 52.61 million a year ago. Basic loss per share from continuing operations was TWD 4.86 compared to TWD 0.38 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.62% | 166M | |
| +0.17% | 42.86B | |
| +10.92% | 42.74B | |
| +44.30% | 41.36B | |
| -6.20% | 27.68B | |
| +5.23% | 25.15B | |
| -24.79% | 18.63B | |
| +26.69% | 12.37B | |
| -3.13% | 11.92B | |
| +6.57% | 11.21B |
MEDIGEN BIOTECHNOLOGY CORP. 
